Skip to content

Multidetector Raw CT as a Single Tool in the Setting of Ischemic Stroke

Evaluation of Multidetector Raw Computerized Tomography in the Etiological Analysis of Acute Ischemic Stroke: the COCASE Protocol.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00708188
Acronym
COCASE
Enrollment
49
Registered
2008-07-02
Start date
2008-03-31
Completion date
2013-04-30
Last updated
2019-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Keywords

Stroke, ischemic, etiology, TOAST, CT, multidetector

Brief summary

This is a prospective study including acute ischemic stroke patients aged 18 to 90. Multidetector raw CT is performed in acute ischemic stroke patients. Heart, neck vessels and brain arteries are studied during the same acquisition. Results are compared with the standard methods including transesophageal echocardiography (TEE), Doppler ultrasound (DUS) and MR angiography (MRA) of neck vessels. The main criteria is the ability of CT to classify the stroke etiology correctly according to the TOAST classification in comparison with the standard methods.

Interventions

DEVICEMultidetector raw CT

Multidetector raw CT

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Acute (\< 1 week) ischemic stroke patient aged 18 to 90 * Informed consent obtained * Presence of health insurance

Exclusion criteria

* Pregnancy or absence of efficient contraceptive method * Allergy * Allergy to contrast material * Asthma * Renal failure (blood creatinine \> 130 µmoles/l, creatinine clearance \< 80 ml/mn according to Cockroft method) * Myeloma * Hyperthyroidism (uncontrolled) * Difficulties to synchronize CT to heart rhythm * Contra-indication to TEE or MRI * Absence or retirement of informed consent * Absence of health insurance

Design outcomes

Primary

MeasureTime frame
Ability of CT to classify the stroke etiology correctly (TOAST classification) in comparison to reference methods (MRA, DUS, TEE)classify the stroke etiology

Secondary

MeasureTime frame
Ability of CT to detect the source of stroke in each etiological group. Reliability of CT in quantitative measures of artery stenosis, aortic atheroma, heart thrombus, heart tumors). Tolerance of CTdetect the source of stroke

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026